Breast Cancer Clinical Trials in Kansas City, MO

Breast Cancer Clinical Trials in Kansas City, MO

View the best 10 breast cancer medical studies in Kansas City, Missouri. Access promising new therapies by applying to a Kansas City-based Breast Cancer clinical trial.

Trials in Kansas City, Missouri

Here are the top 10 medical studies for breast cancer in Kansas City, Missouri

Image of Northwest Georgia Oncology Centers in Marietta, United States.

Sacituzumab Govitecan-hziy

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial will compare a new drug (SG) to current treatments for metastatic breast cancer to see if it can improve life spans. Primary objective is to compare its effect on progression-free survival (PFS).
Image of San Juan Oncology Associates in Farmington, United States.

Disitamab Vedotin

Antibody Drug Conjugate

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug called disitamab vedotin (DV) in combination with a drug called tucatinib for patients with advanced or metastatic solid tumors that express HER
Image of START Midwest in Grand Rapids, United States.

PF-07220060 +1 More

Chemotherapy

Recruiting1 awardPhase 1 & 2
This trial tests two new oral medicines, PF-07220060 and PF-07104091, in people with different types of breast cancer. It aims to find the safest and most effective dose by gradually increasing the amount given to participants. The study will last several years, during which participants will be monitored for safety and treatment effects.
Image of University of Alabama at Birmingham/ Kirklin Clinic in Birmingham, United States.

Endocrine Therapy

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is testing a new drug to see if it is effective and safe to use in patients with a certain type of breast cancer.
Image of Kaiser Permanente-Deer Valley Medical Center in Antioch, United States.

Carvedilol

Recruiting2 awardsPhase 3
This trial studies the effects of carvedilol on preventing heart problems in patients with HER2-positive breast cancer.
Image of Exelixis Clinical Site #6 in Duarte, United States.

XL092

Recruiting1 awardPhase 1
This trial is testing a new drug called XL092 by itself and with two other drugs, atezolizumab and avelumab. It targets patients with advanced solid tumors who may not respond to current treatments. XL092 aims to stop cancer cells from growing, while atezolizumab and avelumab help the immune system fight the cancer. Atezolizumab is approved for various cancers, including breast and urothelial carcinoma, and has shown efficacy in combination with chemotherapy.
Image of START Midwest in Grand Rapids, United States.

BBI-355

Checkpoint Inhibitor

Recruiting1 awardPhase 1
This trial is researching a potential new cancer treatment to see how safe and effective it is.
Image of CBCC Global Research Inc., at Comprehensive Blood and Cancer Center in Bakersfield, United States.

Endocrine Therapy of Physician's Choice +1 More

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Image of Highlands Oncology Group in Fayetteville, United States.

Abemaciclib +1 More

CDK4/6 Inhibitor

Recruiting3 awardsPhase 3
This trial is comparing two treatments for hormone receptor positive, HER2 negative advanced breast cancer. One group will receive abemaciclib + fulvestrant, and the other will just receive fulvestrant. The study will last about 9 months for each participant.
Image of Jackson County Correctional Facility in Kansas City, United States.

SHE-WOMEN

Behavioral Intervention

Recruiting1 award1 criteria
This trial will test an expansion of an existing cervical cancer prevention intervention to a broader population to see if it is effective and sustainable.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.